Molecular Fingerprinting of Lung Cancer
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other, Genetic
Study Type: Observational
SUMMARY
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:
• Diagnosis of non-small cell lung cancer
‣ Clinical stage I and II disease
⁃ Resectable disease and complete surgical resection planned
• Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network
• Tumor specimen samples must be available at resection
Locations
United States
Tennessee
Dan Rudy Cancer Center at Saint Thomas Hospital
COMPLETED
Nashville
Vanderbilt-Ingram Cancer Center
RECRUITING
Nashville
Veterans Affairs Medical Center - Nashville
SUSPENDED
Nashville
Contact Information
Primary
VICC Clinical Trials Information Program
cip@vumc.org
800-811-8480
Time Frame
Start Date: 2001-05
Estimated Completion Date: 2031-05-31
Participants
Target number of participants: 4000
Treatments
Resectable non-small cell lung cancer
Patients with clinical stage I or II invasive lung cancer that can be completely removed by surgery and who have not undergone chemotherapy or radiotherapy before surgery
Authors
Pierre P. Massion
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)